Carlos Spuch

3.4k total citations
73 papers, 2.5k citations indexed

About

Carlos Spuch is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carlos Spuch has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 20 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Carlos Spuch's work include Alzheimer's disease research and treatments (19 papers), Tryptophan and brain disorders (9 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Carlos Spuch is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Tryptophan and brain disorders (9 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Carlos Spuch collaborates with scholars based in Spain, Portugal and Sweden. Carlos Spuch's co-authors include Eva Carro, Carmen Navarro, Saida Ortolano, J.M. Olivares, Desireé Antequera, Roberto Carlos Agís‐Balboa, Tania Rivera‐Baltanás, Daniela Rodrígues-Amorím, José Luís Trejo and Ignacio Torres‐Alemán and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Carlos Spuch

69 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Spuch Spain 28 878 742 477 378 331 73 2.5k
Rena Li United States 23 1.5k 1.7× 744 1.0× 513 1.1× 809 2.1× 257 0.8× 60 2.8k
Maria Giuliana Vannucchi Italy 31 747 0.9× 846 1.1× 619 1.3× 464 1.2× 196 0.6× 93 3.1k
Paweł Grieb Poland 32 471 0.5× 981 1.3× 367 0.8× 628 1.7× 226 0.7× 159 3.5k
Dan Liu China 31 1.2k 1.4× 1.7k 2.3× 633 1.3× 479 1.3× 235 0.7× 80 3.6k
Michael L. Niehoff United States 28 937 1.1× 840 1.1× 510 1.1× 484 1.3× 165 0.5× 76 2.8k
Quanguang Zhang United States 39 791 0.9× 1.5k 2.0× 795 1.7× 1.2k 3.1× 327 1.0× 94 4.4k
Jian‐Zhi Wang China 25 1.0k 1.2× 824 1.1× 542 1.1× 512 1.4× 328 1.0× 62 2.3k
Shannon L. Macauley United States 25 1.9k 2.2× 981 1.3× 433 0.9× 535 1.4× 161 0.5× 49 3.4k
Adina T. Michael‐Titus United Kingdom 35 678 0.8× 1.1k 1.5× 974 2.0× 306 0.8× 136 0.4× 106 3.5k
Fang Cai China 32 1.7k 2.0× 1.8k 2.4× 905 1.9× 555 1.5× 427 1.3× 91 4.2k

Countries citing papers authored by Carlos Spuch

Since Specialization
Citations

This map shows the geographic impact of Carlos Spuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Spuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Spuch more than expected).

Fields of papers citing papers by Carlos Spuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Spuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Spuch. The network helps show where Carlos Spuch may publish in the future.

Co-authorship network of co-authors of Carlos Spuch

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Spuch. A scholar is included among the top collaborators of Carlos Spuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Spuch. Carlos Spuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Sanz, David, et al.. (2025). Effects of Alzheimer’s disease plasma marker levels on multilayer centrality in healthy individuals. Alzheimer s Research & Therapy. 17(1). 8–8. 2 indexed citations
2.
Freire, M., B. Sopeña, Susana B. Bravo, et al.. (2025). Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure. Journal of Clinical Medicine. 14(6). 2019–2019. 1 indexed citations
3.
Mas, Sergi, Manuel J. Cuesta, Benedicto Crespo‐Facorro, et al.. (2025). Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol. Frontiers in Psychiatry. 15. 1497565–1497565.
4.
Spuch, Carlos, et al.. (2024). Sequential release of drugs from dual-delivery plasmonic nanogels containing lipid-gated mesoporous silica-coated gold nanorods. Journal of Drug Delivery Science and Technology. 96. 105723–105723. 6 indexed citations
5.
Veloso, Sérgio R. S., Margarita Vázquez‐González, Carlos Spuch, et al.. (2024). An Injectable Composite Co‐Assembled Dehydropeptide‐Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy. Advanced Functional Materials. 34(38). 7 indexed citations
6.
López‐Sanz, David, et al.. (2024). Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer’s disease. Brain Communications. 6(5). fcae283–fcae283. 3 indexed citations
7.
Rivera‐Baltanás, Tania, Daniela Rodrígues-Amorím, Yolanda Diz-Chaves, et al.. (2023). Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System. Nutrients. 15(14). 3284–3284. 19 indexed citations
8.
Diz-Chaves, Yolanda, et al.. (2022). Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases. International Journal of Molecular Sciences. 23(17). 9583–9583. 75 indexed citations
9.
Veloso, Sérgio R. S., Carlos Spuch, Loïc Hilliou, et al.. (2022). Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels. Nanoscale. 14(14). 5488–5500. 21 indexed citations
10.
Bartolomé, Fernando Benito, Agnieszka Krzyzanowska, Consuelo Pascual, et al.. (2020). Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease. Scientific Reports. 10(1). 9391–9391. 29 indexed citations
11.
Gutiérrez, Olga, et al.. (2019). Rendimiento neuropsicológico de niños y niñas con Trastorno por Déficit de Atención e Hiperactividad (TDAH). SHILAP Revista de lepidopterología. 2 indexed citations
12.
Rodrígues-Amorím, Daniela, Tania Rivera‐Baltanás, João M. Bessa, et al.. (2018). The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis. Journal of Psychiatric Research. 106. 43–53. 46 indexed citations
13.
Fuku, Noriyuki, Roberto Díaz‐Peña, Yasumichi Arai, et al.. (2017). Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE. BMC Genomics. 18(S8). 803–803. 14 indexed citations
14.
Bolós, Marta, Carlos Spuch, Lara Ordóñez‐Gutiérrez, et al.. (2013). Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer’s disease. Cellular and Molecular Life Sciences. 70(15). 2787–2797. 15 indexed citations
15.
Spuch, Carlos, Saida Ortolano, & Carmen Navarro. (2012). Lafora Progressive Myoclonus Epilepsy: Recent Insights into Cell Degeneration. Recent Patents on Endocrine Metabolic & Immune Drug Discovery. 6(2). 99–107. 4 indexed citations
16.
Spuch, Carlos, Saida Ortolano, & Carmen Navarro. (2012). LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease. Frontiers in Physiology. 3. 269–269. 87 indexed citations
17.
Ortolano, Saida, Carlos Spuch, & Carmen Navarro. (2012). Present and Future of Adeno Associated Virus Based Gene Therapy Approaches. Recent Patents on Endocrine Metabolic & Immune Drug Discovery. 6(1). 47–66. 22 indexed citations
18.
Vilar, Marçal, Ioannis Charalampopoulos, Rajappa S. Kenchappa, et al.. (2009). Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. Journal of Cell Science. 122(18). 3351–3357. 46 indexed citations
19.
Spuch, Carlos, Desireé Antequera, María Isabel Fernández‐Bachiller, Marı́a Isabel Rodrı́guez-Franco, & Eva Carro. (2009). A New Tacrine–Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease. Neurotoxicity Research. 17(4). 421–431. 50 indexed citations
20.
Carro, Eva, et al.. (2005). Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I. Journal of Neuroscience. 25(47). 10884–10893. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rena Li Breakdown of academic impact, for papers by Maria Giuliana Vannucchi Breakdown of academic impact, for papers by Paweł Grieb Breakdown of academic impact, for papers by Dan Liu Breakdown of academic impact, for papers by Michael L. Niehoff Breakdown of academic impact, for papers by Quanguang Zhang Breakdown of academic impact, for papers by Jian‐Zhi Wang Breakdown of academic impact, for papers by Shannon L. Macauley Breakdown of academic impact, for papers by Adina T. Michael‐Titus Breakdown of academic impact, for papers by Fang Cai
Rankless by CCL
2026